CD14 and Chagas disease: Our previous studies documenting the design of a DNA vaccine consisting of pCDNA3 encoding TcG2 and TcG4 candidates that provided protection from Trypanosoma cruzi infection in mice and dogs have provided the proof-of-principle for further development of a vaccine against CD14–18.